Axogen, Inc. Lease, Cost
Axogen, Inc. (AXGN) reported Lease, Cost of $1.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-07-29
- Axogen, Inc. lease, cost for the quarter ending 2026-06-30 was $1.34M, a 28.91% increase year-over-year.
- Axogen, Inc. lease, cost for the quarter ending 2026-03-31 was $1.32M, a 20.15% increase year-over-year.
- Axogen, Inc. lease, cost for the quarter ending 2025-12-31 was $2.72M, a 130.93% increase year-over-year.
- Axogen, Inc. lease, cost for the quarter ending 2025-09-30 was $873.00K, a 26.20% decline year-over-year.
- Axogen, Inc. lease, cost for fiscal 2025 was $5.19M, a 7.01% increase from fiscal 2024.
- Axogen, Inc. lease, cost for fiscal 2024 was $4.85M, a 8.04% decline from fiscal 2023.
- Axogen, Inc. lease, cost for fiscal 2023 was $5.27M, a 2.55% decline from fiscal 2022.
- Axogen, Inc. lease, cost for fiscal 2022 was $5.41M, a 6.03% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 6 month as first filed | Lease, Cost 9 month | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.34M 10-Q · filed 2026-07-29 | $2.66M 10-Q · filed 2026-07-29 | $5.38M derived: sum of 3 quarters · filed 2026-07-29 | $6.25M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2026-03-31 | $1.32M 10-Q · filed 2026-04-28 | $4.04M derived: sum of 2 quarters · filed 2026-04-28 | $4.91M derived: sum of 3 quarters · filed 2026-04-28 | $5.95M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.59M derived: sum of 2 quarters · filed 2026-02-24 | $4.63M derived: sum of 3 quarters · filed 2026-07-29 | $5.19M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $873.00K 10-Q · filed 2025-10-29 | $1.91M derived: sum of 2 quarters · filed 2026-07-29 | $2.47M 10-Q · filed 2025-10-29 | $4.19M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-06-30 | $1.04M 10-Q · filed 2026-07-29 | $769.00K 10-Q · filed 2025-08-05 | $2.14M 10-Q · filed 2026-07-29 | $1.60M 10-Q · filed 2025-08-05 | $3.31M derived: sum of 3 quarters · filed 2026-07-29 | $4.50M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | $1.10M 10-Q · filed 2026-04-28 | $828.00K 10-Q · filed 2025-05-08 | $2.27M derived: sum of 2 quarters · filed 2026-04-28 | $3.46M derived: sum of 3 quarters · filed 2026-04-28 | $4.74M derived: sum of 4 quarters · filed 2026-04-28 | ||
| 2024-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.36M derived: sum of 2 quarters · filed 2026-02-24 | $3.64M derived: sum of 3 quarters · filed 2026-02-24 | $4.85M 10-K · filed 2026-02-24 | $4.86M 10-K · filed 2025-02-26 | ||
| 2024-09-30 | $1.18M 10-Q · filed 2025-10-29 | $2.47M derived: sum of 2 quarters · filed 2025-10-29 | $3.67M 10-Q · filed 2025-10-29 | $5.08M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | $1.28M 10-Q · filed 2025-08-05 | $1.28M 10-Q · filed 2024-08-08 | $2.49M 10-Q · filed 2025-08-05 | $2.49M 10-Q · filed 2024-08-08 | $3.89M derived: sum of 3 quarters · filed 2026-02-24 | $5.22M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $1.21M 10-Q · filed 2025-05-08 | $2.61M derived: sum of 2 quarters · filed 2026-02-24 | $3.94M derived: sum of 3 quarters · filed 2026-02-24 | $5.18M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.73M derived: sum of 2 quarters · filed 2026-02-24 | $3.97M derived: sum of 3 quarters · filed 2026-02-24 | $5.27M 10-K · filed 2026-02-24 | $5.28M 10-K · filed 2024-03-05 | ||
| 2023-09-30 | $1.33M 10-Q · filed 2024-11-07 | $2.57M derived: sum of 2 quarters · filed 2024-11-07 | $3.87M 10-Q · filed 2024-11-07 | $5.18M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $1.24M 10-Q · filed 2024-08-08 | $2.54M 10-Q · filed 2024-08-08 | $3.85M derived: sum of 3 quarters · filed 2025-02-26 | $5.19M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | $1.30M 10-Q · filed 2024-05-02 | $2.61M derived: sum of 2 quarters · filed 2025-02-26 | $3.95M derived: sum of 3 quarters · filed 2025-02-26 | $5.30M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $2.65M derived: sum of 2 quarters · filed 2025-02-26 | $4.00M derived: sum of 3 quarters · filed 2025-02-26 | $5.41M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $1.34M 10-Q · filed 2023-11-07 | $2.69M derived: sum of 2 quarters · filed 2023-11-07 | $4.10M 10-Q · filed 2023-11-07 | $5.55M derived: sum of 4 quarters · filed 2024-03-05 | |||
| 2022-06-30 | $1.35M 10-Q · filed 2023-08-08 | $2.76M 10-Q · filed 2023-08-08 | $4.21M derived: sum of 3 quarters · filed 2024-03-05 | $5.43M derived: sum of 4 quarters · filed 2024-03-05 | |||
| 2022-03-31 | $1.41M 10-Q · filed 2023-05-09 | $2.86M derived: sum of 2 quarters · filed 2024-03-05 | $4.07M derived: sum of 3 quarters · filed 2024-03-05 | $5.28M derived: sum of 4 quarters · filed 2024-03-05 | |||
| 2021-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $2.66M derived: sum of 2 quarters · filed 2024-03-05 | $3.87M derived: sum of 3 quarters · filed 2024-03-05 | $5.10M 10-K · filed 2024-03-05 | |||
| 2021-09-30 | $1.21M 10-Q · filed 2022-11-08 | $2.42M derived: sum of 2 quarters · filed 2022-11-08 | $3.65M 10-Q · filed 2022-11-08 | $4.76M derived: sum of 4 quarters · filed 2023-03-14 | |||
| 2021-06-30 | $1.21M 10-Q · filed 2022-08-05 | $2.44M 10-Q · filed 2022-08-05 | $3.55M derived: sum of 3 quarters · filed 2023-03-14 | $4.31M derived: sum of 4 quarters · filed 2023-03-14 | |||
| 2021-03-31 | $1.23M 10-Q · filed 2022-05-05 | $2.34M derived: sum of 2 quarters · filed 2023-03-14 | $3.10M derived: sum of 3 quarters · filed 2023-03-14 | $3.66M derived: sum of 4 quarters · filed 2023-03-14 | |||
| 2020-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.88M derived: sum of 2 quarters · filed 2023-03-14 | $2.44M derived: sum of 3 quarters · filed 2023-03-14 | $2.94M 10-K · filed 2023-03-14 | |||
| 2020-09-30 | $761.00K 10-Q · filed 2021-11-04 | $1.32M derived: sum of 2 quarters · filed 2021-11-04 | $1.82M 10-Q · filed 2021-11-04 | $2.31M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-06-30 | $559.00K 10-Q · filed 2021-08-05 | $1.06M 10-Q · filed 2021-08-05 | $1.54M derived: sum of 3 quarters · filed 2022-02-25 | $2.05M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-03-31 | $502.00K 10-Q · filed 2021-05-06 | $986.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.49M derived: sum of 3 quarters · filed 2022-02-25 | $1.99M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2019-12-31 | $484.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $985.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.49M derived: sum of 3 quarters · filed 2022-02-25 | $1.99M 10-K · filed 2022-02-25 | |||
| 2019-09-30 | $501.00K 10-Q · filed 2020-10-30 | $1.00M derived: sum of 2 quarters · filed 2020-10-30 | $1.51M 10-Q · filed 2020-10-30 | ||||
| 2019-06-30 | $501.00K 10-Q · filed 2020-08-07 | $1.01M 10-Q · filed 2020-08-07 | |||||
| 2019-03-31 | $507.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |